Ticker Details
NeoGenomics, Inc. NeoGenomics Inc operates a network of cancer-related testing laboratories in Ft. Myers and Tampa, Florida, Irvine, California and Nashville, and Tennessee.
IPO Date:	December 10, 2012
Sector:	Healthcare
Industry:	Life Sciences Tools and Services
Market Cap:	$1.92B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.37 | 2.53%
Avg Daily Range (30 D):	$0.39 | 3.39%
Avg Daily Range (90 D):	$0.29 | 2.97%

Institutional Daily Volume
Avg Daily Volume:	.75M
Avg Daily Volume (30 D):	2.44M
Avg Daily Volume (90 D):	1.84M

Trade Size
Avg Trade Size (Sh.):	95
Avg Trade Size (Sh.) (30 D):	97
Avg Trade Size (Sh.) (90 D):	84

Institutional Trades
Total Institutional Trades:	4,092
Avg Institutional Trade:	$2.19M
Avg Institutional Trade (30 D):	$2.72M
Avg Institutional Trade (90 D):	$2.71M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.78M
Avg Closing Trade (30 D):	$5.52M
Avg Closing Trade (90 D):	$3.62M
Avg Closing Volume:	164.06K

News

Jun 25, 2025 @ 6:51 AM 3 Hot Trades for Insiders, But Are They Good Buys ... Source: Marketbeat.Com

May 6, 2025 @ 4:20 PM It's Not Too Late to Jump on These Under-the-Radar... Source: Marketbeat.Com

Apr 8, 2025 @ 8:48 AM Minimal Residual Disease Testing Market Forecast R... Source: Researchandmarkets.Com

Feb 17, 2025 @ 10:28 PM Not Just a DEX: How Pineapple’s Mystery Mar... Source: N/A

Jan 15, 2025 @ 3:10 PM Cutting-Edge Cancer Therapies Lead the Way into a ... Source: Prnewswire

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS
Diluted EPS
Revenue	$745.97M	$186.67M	$190.17M
Gross Profit	$321.91M	$80.86M	$83.34M
Net Income / Loss	$-99.21M	$-17.11M	$-9.88M
Operating Income / Loss	$-106.3M	$-18.24M	$-13.41M
Cost of Revenue	$424.06M	$105.81M	$106.83M
Net Cash Flow	$-200.05M	$-13.48M	$-4.53M
PE Ratio

Splits
Apr 16, 2003	1:100
Nov 17, 2000	4:1